Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 9INDUSTRY 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 210Breast Neoplasms 116Neoplasms 111Colorectal Neoplasms 94Multiple Myeloma 87Prostatic Neoplasms 83Neoplasm Metastasis 71Ovarian Neoplasms 69Lung Neoplasms 67Recurrence 57Squamous Cell Carcinoma of Head and Neck 55Pancreatic Neoplasms 47Stomach Neoplasms 42Leukemia, Lymphocytic, Chronic, B-Cell 41Lymphoma, Large B-Cell, Diffuse 39Small Cell Lung Carcinoma 38Melanoma 37Lymphoma, Non-Hodgkin 37Leukemia, Myeloid, Acute 37Parkinson Disease 4, Autosomal Dominant Lewy Body 36Carcinoma, Renal Cell 36Advanced Solid Tumors 35Endometrial Neoplasms 34Triple Negative Breast Neoplasms 29Lymphoma, Follicular 29Urinary Bladder Neoplasms 26Head and Neck Neoplasms 26Carcinoma, Hepatocellular 25Myasthenia Gravis 23Esophageal Neoplasms 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Cognitive Dysfunction × 30 days × Clear all
NCT05637801 2026-05-05

HOPE

Cognito Therapeutics, Inc.

Phase NA Active not recruiting
670 enrolled
Lymphoid

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT07563777 2026-05-04

100-Year Human Aging Study

Longevity Metrics, Inc.

Recruiting
10,000 enrolled

Frailty, Cardiovascular Diseases, Dementia, Musculoskeletal Diseases, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡